Upgrade to see committee overlap, performance context, and full expert analysis.
XOM congressional trades
26 matched disclosures
XOM congressional trades snapshot
This page summarizes public STOCK Act disclosures involving XOM. It is useful for seeing which lawmakers reported XOM transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Jun 17, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
What the XOM congressional trade page shows
Congressional Trader tracks 26 public STOCK Act disclosures for XOMacross 16 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent XOM filing shown here was filed on Jun 17, 2026 by Matt Van Epps as a sale. Related lawmakers include Jefferson Shreve, Kevin Hern, Bruce Westerman, Greg Landsman, Jared Moskowitz.
Top lawmakers for XOM
Pro performance summary
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansUpgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
FAQ
Which lawmakers traded XOM?
Recent XOM disclosures include Jefferson Shreve, Kevin Hern, Bruce Westerman, Greg Landsman, Jared Moskowitz.
What is the buy/sell mix for XOM?
The visible sample currently shows 15 purchases and 11 sales or partial sales.
Should I trade based on XOM disclosures?
No. This page summarizes public filings for research and monitoring. It is not investment advice.